| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 11, 695-702, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
V Mansat, A Bettaieb, T Levade, G Laurent and JP Jaffrezou
CJF INSERM 9503, Centre Claudius Regaud, Toulouse, France.
To address the role of a plausible protease cascade in daunorubicin- triggered apoptosis, we evaluated the effect of cell-permeant protease inhibitors on its signal transduction pathway. Treatment of U937 and HL- 60 cells with 0.5-1 microM of the chemotherapeutic drug daunorubicin induced a greater than 30% activation of neutral sphingomyelinase activity within 4-10 min with concomitant sphingomyelin hydrolysis and ceramide generation. DNA fragmentation and the classical morphological features of apoptosis were observed within 4-6 h. Pretreatment of cells with the serine protease inhibitors N-tosyl-L-phenylalanyl chloromethyl ketone (20 microM) or dichloroisocoumarin (20 microM) for 30 min inhibited daunorubicin-induced neutral sphingomyelinase activation, sphingomyelin hydrolysis, ceramide generation, and apoptosis. Other cell-permeant protease inhibitors such as pepstatin, leupeptin, and antipain had no such effect. The apoptotic response could be restored by the addition of 25 microM cell-permeant C6-ceramide. Daunorubicin- induced NF-kappaB activation was inhibited by dichloroisocoumarin but not by N-tosyl-L-phenylalanyl chloromethyl ketone, suggesting that this transcription factor can be activated independently of ceramide and is not directly implicated in the apoptotic pathway. These results suggest that inhibitors of serine proteases can act upstream of ceramide in drug-triggered apoptosis and that neutral sphingomyelinase activation is either directly or indirectly serine protease dependent.
This article has been cited by other articles:
|
|
 |
|
  A. D. Schimmer, D. W. Hedley, L. Z. Penn, and M. D. Minden Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view Blood, December 15, 2001; 98(13): 3541 - 3553. [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Watts, B. W. Futscher, R. Isett, M. Gleason-Guzman, M. W. Kunkel, and S. E. Salmon cDNA Microarray Analysis of Multidrug Resistance: Doxorubicin Selection Produces Multiple Defects in Apoptosis Signaling Pathways J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 434 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Laurent and J.-P. Jaffrezou Signaling pathways activated by daunorubicin Blood, August 15, 2001; 98(4): 913 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Maestre, T. R. Tritton, G. Laurent, and J.-P. Jaffrézou Cell Surface-directed Interaction of Anthracyclines Leads to Cytotoxicity and Nuclear Factor {{kappa}}B Activation but not Apoptosis Signaling Cancer Res., March 1, 2001; 61(6): 2558 - 2561. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ferraro, L. Quemeneur, A.-F. Prigent, C. Taverne, J.-P. Revillard, and N. Bonnefoy-Berard Anthracyclines Trigger Apoptosis of Both G0-G1 and Cycling Peripheral Blood Lymphocytes and Induce Massive Deletion of Mature T and B Cells Cancer Res., April 1, 2000; 60(7): 1901 - 1907. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Chatterjee, H. Han, S. Rollins, and T. Cleveland Molecular Cloning, Characterization, and Expression of a Novel Human Neutral Sphingomyelinase J. Biol. Chem., December 24, 1999; 274(52): 37407 - 37412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M.-D. Mas, C. Bezombes, A. Quillet-Mary, A. Bettaïeb, A. D. T. D'orgeix, G. Laurent, and J.-P. Jaffrézou Implication of Radical Oxygen Species in Ceramide Generation, c-Jun N-Terminal Kinase Activation and Apoptosis Induced by Daunorubicin Mol. Pharmacol., November 1, 1999; 56(5): 867 - 874. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Delpy, S. N Hatem, N. Andrieu, C. de Vaumas, M. Henaff, C. Rucker-Martin, J.-P. Jaffrezou, G. Laurent, T. Levade, and J.-J. Mercadier Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes Cardiovasc Res, August 1, 1999; 43(2): 398 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Auge, M. Nikolova-Karakashian, S. Carpentier, S. Parthasarathy, A. Negre-Salvayre, R. Salvayre, A. H. Merrill Jr., and T. Levade Role of Sphingosine 1-Phosphate in the Mitogenesis Induced by Oxidized Low Density Lipoprotein in Smooth Muscle Cells via Activation of Sphingomyelinase, Ceramidase, and Sphingosine Kinase J. Biol. Chem., July 30, 1999; 274(31): 21533 - 21538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bettaïeb, I. Plo, V. Mansat-De Mas, A. Quillet-Mary, T. Levade, G. Laurent, and J.-P. Jaffrézou Daunorubicin- and Mitoxantrone-Triggered Phosphatidylcholine Hydrolysis: Implication in Drug-Induced Ceramide Generation and Apoptosis Mol. Pharmacol., January 1, 1999; 55(1): 118 - 125. [Abstract] [Full Text]
|
|
|
|
|
|
I. Escargueil-Blanc, N. Andrieu-Abadie, S. Caspar-Bauguil, R. Brossmer, T. Levade, A. Negre-Salvayre, and R. Salvayre Apoptosis and Activation of the Sphingomyelin-Ceramide Pathway Induced by Oxidized Low Density Lipoproteins Are Not Causally Related in ECV-304 Endothelial Cells J. Biol. Chem., October 16, 1998; 273(42): 27389 - 27395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Auge, I. Escargueil-Blanc, I. Lajoie-Mazenc, I. Suc, N. Andrieu-Abadie, M.-T. Pieraggi, M. Chatelut, J.-C. Thiers, J.-P. Jaffrezou, G. Laurent, et al. Potential Role for Ceramide in Mitogen-activated Protein Kinase Activation and Proliferation of Vascular Smooth Muscle Cells Induced by Oxidized Low Density Lipoprotein J. Biol. Chem., May 22, 1998; 273(21): 12893 - 12900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Paris, H. Grassme, A. Cremesti, J. Zager, Y. Fong, A. Haimovitz-Friedman, Z. Fuks, E. Gulbins, and R. Kolesnick Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes J. Biol. Chem., March 9, 2001; 276(11): 8297 - 8305. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
